Savara Inc
Savara Inc
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 42 | 39 | 33 | 16 | 17 | 20 | 15 | 21 | 24 | 17 | 27 | 28 | |||||
Short Term Investments | 131 | 164 | 203 | 108 | 129 | 153 | 181 | 198 | 98 | 126 | 136 | 141 | |||||
Prepaid Expense And Other Assets Current | 5 | 6 | 6 | 4 | 5 | 5 | 6 | 7 | 6 | 3 | 4 | 2 | |||||
Assets Current | 178 | 209 | 242 | 128 | 151 | 177 | 202 | 226 | 128 | 146 | 166 | 170 | |||||
Property Plant And Equipment Net | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 2 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | |||||
Assets | 192 | 222 | 253 | 141 | 164 | 189 | 213 | 239 | 140 | 158 | 178 | 182 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 7 | 4 | 6 | 4 | 5 | 6 | 5 | 5 | 3 | 3 | 4 | 3 | |||||
Accrued Liabilities Current | 11 | 11 | 15 | 13 | 9 | 6 | 10 | 8 | 8 | 7 | 7 | 6 | |||||
Long Term Debt Current | - | - | - | - | - | 0 | - | - | - | - | - | - | |||||
Liabilities Current | 18 | 16 | 20 | 17 | 14 | 12 | 15 | 13 | 11 | 10 | 11 | 9 | |||||
Liabilities Noncurrent | |||||||||||||||||
Long Term Debt Noncurrent | 30 | 30 | 30 | 30 | 30 | 30 | 27 | 27 | 26 | 26 | 26 | 26 | |||||
Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 48 | 46 | 50 | 47 | 43 | 41 | 41 | 39 | 38 | 36 | 37 | 36 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 830 | 822 | 811 | 670 | 667 | 664 | 661 | 659 | 538 | 536 | 534 | 525 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -0 | -0 | -0 | -0 | -1 | -1 | 0 | -1 | -1 | -0 | -1 | |||||
Retained Earnings Accumulated Deficit | -686 | -645 | -608 | -576 | -546 | -516 | -489 | -460 | -436 | -414 | -393 | -377 | |||||
Stockholders Equity | 144 | 176 | 203 | 94 | 120 | 148 | 171 | 199 | 102 | 122 | 140 | 147 | |||||
Liabilities And Stockholders Equity | 192 | 222 | 253 | 141 | 164 | 189 | 213 | 239 | 140 | 158 | 178 | 182 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 600 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 205 | 205 | 205 | - | 173 | 173 | 172 | 171 | 138 | 138 | 138 | 135 | |||||
Shares Outstanding | 205 | 205 | 205 | - | 173 | 173 | 172 | 171 | 138 | 138 | 138 | 135 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.20% | 22.44% | 9.06% | - | - | - | - | - | - | - | - | - |
| 2025 | -17.85% | -26.26% | -12.79% | 37.78% | 29.26% | 53.70% | 57.77% | 36.89% | 31.07% | 5.90% | -2.48% | -0.95% |
| 2024 | -19.33% | -20.51% | -12.03% | 7.80% | -6.83% | -12.20% | -2.87% | -18.02% | -29.50% | 8.27% | 10.43% | -20.50% |
| 2023 | - | - | - | - | - | - | 14.37% | 37.83% | 40.76% | -10.91% | -21.11% | -27.01% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 10.13 | 13.47 | 11.85 | 7.65 | 11.08 | 14.91 | 13.73 | 17.70 | 11.31 | 14.90 | 15.66 | 18.98 | |||||
| Quick Ratio | 9.83 | 13.05 | 11.56 | 7.42 | 10.75 | 14.50 | 13.33 | 17.16 | 10.77 | 14.58 | 15.32 | 18.77 | |||||
| Working Capital | 160.72M | 193.73M | 221.22M | 111.44M | 137.36M | 165.55M | 187.41M | 213.61M | 116.41M | 136.38M | 155.35M | 161.13M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.34 | 0.26 | 0.25 | 0.49 | 0.36 | 0.28 | 0.24 | 0.20 | 0.37 | 0.30 | 0.26 | 0.24 | |||||
| Interest Coverage TTM | -39.58 | -36.04 | -29.68 | -24.86 | -18.17 | -16.51 | -15.96 | -14.76 | -15.10 | -14.01 | -13.53 | -15.08 | |||||
| Debt Ratio | 0.25 | 0.21 | 0.20 | 0.33 | 0.26 | 0.22 | 0.19 | 0.17 | 0.27 | 0.23 | 0.21 | 0.20 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.55 | -0.51 | -0.53 | -0.53 | -0.51 | -0.47 | -0.48 | -0.39 | -0.41 | -0.35 | -0.33 | -0.28 | |||||
| Free Cash Flow Per Share TTM | -0.44 | -0.42 | -0.45 | -0.46 | -0.46 | -0.44 | -0.45 | -0.38 | -0.39 | -0.33 | -0.31 | -0.25 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 26.26% | 26.73% | 23.94% | 39.44% | 46.55% | 58.44% | 75.29% | 69.61% | 76.37% | 59.59% | 43.38% | 24.87% | |||||
| EPS Growth (1Y) | 7.77% | 8.15% | 10.46% | 36.47% | 23.63% | 33.81% | 46.12% | 39.86% | 47.60% | 33.57% | 32.59% | 9.20% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -11.21 | -10.68 | -11.28 | -6.68 | -4.47 | -5.86 | -6.35 | -10.83 | -9.77 | -14.10 | -14.20 | -13.50 | |||||
| P/B TTM | 10.87 | 7.86 | 6.60 | 8.19 | 4.10 | 4.05 | 3.55 | 4.51 | 7.23 | 7.46 | 5.53 | 4.51 | |||||
| Market Cap | 1.56B | 1.38B | 1.34B | 772.77M | 493.46M | 598.73M | 608.45M | 898.23M | 735.81M | 909.10M | 776.46M | 660.35M | |||||
| Enterprise Value | 1.55B | 1.37B | 1.34B | 786.27M | 505.68M | 608.70M | 619.94M | 903.36M | 738.43M | 918.73M | 776.22M | 658.94M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -110.66M | -106.97M | -101.06M | -99.29M | -99.43M | -95.67M | -89.13M | -81.47M | -72.00M | -59.98M | -51.36M | -44.38M | |||||
| Net Debt | -11.69M | -8.72M | -3.27M | 13.50M | 12.22M | 9.97M | 11.49M | 5.13M | 2.62M | 9.63M | -237.00K | -1.41M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Savara Inc (SVRA) — SEC Financial Statements & Analysis
Savara Inc (SVRA) is a pharmaceutical preparations company, incorporated in DE. Savara Inc trades on Nasdaq as: SVRA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Savara Inc reported a Debt-to-Equity ratio of 0.34x, a Price-to-Book (P/B) ratio of 10.87x (TTM), at a market cap of $1.56B. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.34x
- P/B TTM
- 10.87x
- Market Cap
- $1.56B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Savara Inc in?
Savara Inc (SVRA) operates in the Pharmaceutical Preparations industry.
What is SVRA's market cap?
Savara Inc (SVRA) has a market capitalization of $1.56B as of 2026-06-30.
What exchange does SVRA trade on?
Savara Inc (SVRA) trades on the Nasdaq.
Where is Savara Inc incorporated?
Savara Inc is incorporated in DE.